AAPS PharmSciTech

, Volume 7, Issue 1, pp E1-E9

First online:

Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of Zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers

  • Atul KuksalAffiliated withDepartment of Pharmaceutical Sciences and Drug Research, Punjabi University
  • , Ashok K. TiwaryAffiliated withDepartment of Pharmaceutical Sciences and Drug Research, Punjabi University
  • , Narendra K. JainAffiliated withDepartment of Pharmaceutical Sciences, Dr Hari Singh Gour University
  • , Subheet JainAffiliated withDepartment of Pharmaceutical Sciences and Drug Research, Punjabi University Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


The aim of the present study was to prepare and characterize extended-release matrix tablets of zidovudine using hydrophilic Eudragit RLPO and RSPO alone or their combination with hydrophobic ethyl cellulose. Release kinetics was evaluated by using United States Pharmacopeia (USP)-22 type I dissolution apparatus. Scanning electron microscopy was used to visualize the effect of dissolution medium on matrix tablet surface. Furthermore, the in vitro and in vivo newly formulated sustained-release zidovudine tablets were compared with conventional marketed tablet (Zidovir, Cipla Ltd, Mumbai, India). The in-vitro drug release study revealed that either Eudragit preparation was able to sustain the drug release only for 6 hours (94.3%±4.5% release). Combining Eudragit with ethyl cellulose sustained the drug release for 12 hours (88.1%±4.1% release). Fitting the in vitro drug release data to Korsmeyer equation indicated that diffusion along with erosion could be the mechanism of drug release. In vivo investigation in rabbits showed sustained-release pharmacokinetic profile of zidovudine from the matrix tablets formulated using combination of Eudragits and ethylcellulose. In conclusion, the results suggest that the developed sustained-release tablets of zidovudine could perform therapeutically better than conventional dosage forms, leading to improve efficacy and better patient compliance.


anti-HIV drug Zidovudine matrix tablets sustained release mechanism scanning electron microscopy